Table 4

 Features associated with antiphospholipid (aPL) syndrome but not included in the revised classification criteria (non-criteria aPL features) (n = 183)

Non-criteria featuresVE with or without PM n = 82 (%)PM only n = 19 (%)Asymptomatic n = 82 (%)
aCL, anticardiolipin; aβ2GPI, anti-β2-glycoprotein-I; aPL, antiphospholipid; PM, pregnancy morbidity; VE, vascular event.
*Based on 78 patients with echocardiogram reports.
†Titres above laboratory normal limits.
‡Titres above laboratory normal limits based on 12 patients who were tested for antiprothrombin antibody, antiphosphatidylserine antibody, antiphosphatidylserine-prothrombin antibody or antiphosphatidylethanolamine antibody.
Livedo reticularis16/82 (20)3/19 (16)3/82 (4)
Cardiac valve disease*11/44 (25)0/6 (0)2/28 (7)
Thrombocytopenia11/82 (13)0/19 (0)5/82 (6)
Nephropathy5/82 (6)1/19 (5)1/82 (1)
Positive aCL IgA†3/82 (4)2/19 (11)13/82(16)
Positive aβ2GPI IgA†1/53 (2)0/6 (0)3/46 (7)
Other aPL‡5/6 (83)0/01/6 (17)